These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 6372798)

  • 21. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
    Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW
    J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages.
    Petty HR; Ware BR; Remold HG; Rocklin RE
    J Immunol; 1980 Jan; 124(1):381-7. PubMed ID: 6153099
    [No Abstract]   [Full Text] [Related]  

  • 24. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
    Balakrishnan K; Hanjan SN; Talwar JP
    Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
    [No Abstract]   [Full Text] [Related]  

  • 26. [Macrophage depletion test in guinea pigs].
    Zschiesche W
    Allerg Immunol (Leipz); 1976; 22(1):105-8. PubMed ID: 135493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.
    Sobel AT; Branellec AI; Blanc CJ; Lagrue GA
    J Immunol; 1977 Oct; 119(4):1230-4. PubMed ID: 894032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphokines and thrombosis. I. Thrombocyte aggregating activity released by human lymphocytes stimulated with concanavalin-A.
    Coeugniet E; Bendixen G
    Acta Allergol; 1976 Apr; 31(2):94-106. PubMed ID: 947142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of migration of tumor cells in vitro by lymphokine-containing supernatants.
    Cohen MC; Goss A; Yoshida T; Cohen S
    J Immunol; 1978 Sep; 121(3):840-3. PubMed ID: 99477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes.
    David JR; Coyne JA; Rocklin RE; Nathan CF; Remold HG
    Transplant Proc; 1972 Jun; 4(2):241-2. PubMed ID: 4113698
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization and purification of mouse macrophage procoagulant-inducing factor.
    Ryan J; Geczy CL
    J Immunol; 1986 Nov; 137(9):2864-70. PubMed ID: 3760575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Products of activated lymphocytes. I. The use of radiolabeling techniques in the characterization and partial purification of the migration inhibition factor of the guinea pig.
    Sorg C; Bloom BR
    J Exp Med; 1973 Jan; 137(1):148-70. PubMed ID: 4688317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Certain characteristics of human lymphocyte migration inhibitory factors (LyMIF) and the effect of ampicillin on their appearance in unstimulated and PHA-stimulated cultures.
    Skopińska-Rózewska E; Madaliński W; Lukasik R
    Acta Physiol Pol; 1983; 34(3):353-67. PubMed ID: 6372368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
    Greineder DK; Rocklin RE; David JR
    J Immunol; 1979 Dec; 123(6):2804-7. PubMed ID: 227960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inability to block the activity of guinea pig migration inhibitory factor with di-isopropyl phosphorofluoridate.
    David JR; Becker EL
    Eur J Immunol; 1974 Apr; 4(4):287-9. PubMed ID: 4604594
    [No Abstract]   [Full Text] [Related]  

  • 37. The induction of macrophage proliferation in vitro by a lymphocyte-produced factor.
    Hadden JW; Sadlik JR; Hadden EM
    J Immunol; 1978 Jul; 121(1):231-8. PubMed ID: 670701
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of the lymphokine responsible for migration-inhibitory activity against tumor cells.
    Cohen MC
    Cancer Res; 1982 Jun; 42(6):2135-8. PubMed ID: 6978764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A lymphokine resembling transfer factor that stimulates MIF production by nonsensitive lymphocytes.
    Philp JR; McCormack JG; Moore AL; Johnson JE
    J Immunol; 1981 Apr; 126(4):1469-72. PubMed ID: 7009741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages.
    Nacy CA; Leonard EJ; Meltzer MS
    J Immunol; 1981 Jan; 126(1):204-7. PubMed ID: 7005333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.